Stay updated on Carboplatin and Nivolumab in mTNBC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin and Nivolumab in mTNBC Clinical Trial page.

Latest updates to the Carboplatin and Nivolumab in mTNBC Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe changes are limited to revision notes (Revision: v3.4.2) and removal of an outdated funding-status notice, with no impact on trial content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedAdded a government funding notice about potential delays and updated the page revision to v3.4.1, replacing the previous revision v3.4.0.SummaryDifference0.4%

- Check47 days agoChange DetectedAdded Show glossary; added QC metadata labels 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and updated the revision label to 'Revision: v3.4.0'. Removed older QC metadata labels 'Last Update Submitted that met QC Criteria' and 'Last Update Posted (Estimated)' as well as 'No FEAR Act data'.SummaryDifference0.2%

- Check61 days agoChange DetectedA new revision label v3.3.4 was added and v3.3.3 was removed, a minor metadata update that does not affect study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedThe Locations section now lists additional sites: Connecticut, Maine, Massachusetts, New Hampshire, Ohio, and Vermont. The HHS Vulnerability Disclosure notice was removed and the page revision updated to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Carboplatin and Nivolumab in mTNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin and Nivolumab in mTNBC Clinical Trial page.